Log in to your Inderes Free account to see all free content on this page.

NanoEcho

0.05 SEK

0.00%

Less than 1K followers

NANECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

0.00 %
+64.90 %
-30.03 %
-34.29 %
-25.29 %
-54.90 %
-
-
-66.79 %

NanoEcho operates in the healthcare sector, with a primary focus on rectal cancer diagnostics. The company is currently in the clinical stage, developing a new diagnostic method to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide an accurate diagnosis and personalized treatment. NanoEcho was founded in 2013 and is headquartered in Lund.

Read more
Market cap
23.2M SEK
Turnover
31.16K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
30.4.
2026

Interim report Q1'26

28.5.
2026

General meeting '26

25.8.
2026

Interim report Q2'26